Secteur Arcturus Therapeutics Holdings Inc.

Actions

ARCT

US03969T1097

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 22/07/2026 Varia. 5j. Varia. 1 janv.
5,930 USD -1,00% Graphique intraday de Arcturus Therapeutics Holdings Inc. -6,91% -3,26%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-1,00%-6,91%-21,25%-32,77%-3,26%-57,00%-82,48%-82,00% - 170 M
-0,43%-1,26%+22,57%+27,75%+38,90%+52,13%+85,69%-24,52% - 55,57 Md
-0,24%-0,37%-1,99%+10,49%+5,80%+57,02%+54,21%+183,30%+5 919,05% 54,26 Md
-0,54%+1,58%+1,03%-17,72%-3,54%-15,68%-15,43%-64,63% - 23,35 Md
-1,82%-3,15%+11,32%-24,36%-38,73%+3,76%+405,88%+309,84%+854,70% 23,54 Md
+0,05%+1,68%+26,02%+10,03%+23,54%+38,71%-4,57%-70,53% - 20,32 Md
+3,16%+2,74%+16,77%+10,33%-5,72%+37,33%-31,36%-31,23%+65,17% 17,36 Md
+1,08%+3,77%+24,34%+3,30%+31,82%+36,92%+593,96% - - 15,59 Md
+0,43%-1,67%+23,49%+101,38%+178,50%+166,53%+299,61%+1 558,20%+608,58% 14,96 Md
-2,03%-1,42%+5,91%+19,81%+25,44%+24,22%+179,23%+222,84%+540,05% 14,11 Md
-1,67%+0,15%+6,31%+1,89%-7,67%+62,46%+149,20%+474,35% - 12,61 Md
+4,55%+3,18%+12,96%-32,58%-12,48%-29,61%+165,86%+88,56% - 11,11 Md
+1,33%+0,32%+4,33%+24,91%+29,35%+122,38%+151,19%+180,70%+725,20% 11,01 Md
+0,75%-4,72%+7,20%-44,12%-15,72%-44,04%+637,00%+92,68%+106,15% 11,36 Md
+19,03%+23,35%+8,41%+24,84%+33,60%+502,99%+145,84%+30,29%+1 489,61% 10,5 Md
+0,02%0,00%+0,43%+15,71%+23,23%+50,33%+177,13% - - 9,83 Md
-0,21%+0,01%+133,40%+115,22%+79,85%+170,50%+347,46%+323,90% - 8,85 Md
+0,70%+4,00%+25,26%-25,78%+19,17%+22,92%+97,24%-14,16% - 8,92 Md
-3,44%+0,22%+12,26%+39,15%+202,72%+506,54%+568,71%-42,17%-12,63% 9,03 Md
-1,34%+11,06%+54,38%+37,09%+25,99%+36,76%+365,81%+338,86% - 8,84 Md
Moyenne +0,95%+0,15%+18,66%+13,23%+31,54%+87,26%+214,51%+193,02%+1 143,99% 17,06 Md
Moyenne pondérée par Capi. +0,53%+0,10%+16,14%+13,68%+25,83%+71,02%+177,93%+172,58%+2 310,71%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action ARCT
  4. Secteur Arcturus Therapeutics Holdings Inc.